abstract |
Medicinal preparations, characterized by a combination of cytostatic agents or hormonal therapeutic agents and one or more phosphone derivatives (in particular geminal diphosphonates, phosphonocarboxylic acids or aminopoly(methylene phosphonic acids)), can be used in cancer therapy, in particular in the therapy of malignancies metastasizing in bone. |